Butterfly Network (BFLY) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Achieved Q3 2024 revenue of $20.6 million, up 33% year-over-year, with strong growth in both U.S. and international markets and record sales performance.
Net loss narrowed to $16.9 million from $27.4 million in Q3 2023, reflecting cost reductions and operational efficiencies.
Expanded internationally with launches in Europe and Asia, introduced iQ3 and new AI-powered education applications, and formed the Octiv subsidiary.
Continued investment in R&D, differentiated technology, and environmental initiatives, including Ultrasound-on-Chip and RoHS compliance.
Strengthened leadership team with the appointment of a new EVP and Chief Business Officer.
Financial highlights
Q3 2024 revenue reached $20.6 million, a 33% increase year-over-year; U.S. revenue was $13.1 million (up 27%), international revenue $5.2 million (up 36%).
Product revenue grew 55% to $13.5 million; software and services revenue up 5% to $7.0 million.
Gross profit was $12.2 million, with gross margin at 59.5% (down from 60.8%); adjusted gross margin was 60.0%.
Operating expenses decreased 30% to $29.5 million; adjusted EBITDA loss improved to $8.4 million from $12.5 million.
Cash, cash equivalents, and restricted cash stood at $97.8 million as of September 30, 2024; cash use reduced to $8.3 million in Q3.
Outlook and guidance
Raised 2024 revenue guidance to $79–$81 million (over 20% growth); improved adjusted EBITDA loss guidance to $40–$42 million.
Q4 2024 expected revenue of $20–$22 million and adjusted EBITDA loss of $10–$12 million.
2025 outlook projects at least 15–20% top-line growth and closing of non-dilutive capital through Powered by Butterfly.
Targeting cash flow break-even by 2027 and $500 million revenue within five years; cash runway expected to extend into 2027.
Latest events from Butterfly Network
- AI-powered handheld ultrasound and new partnerships set stage for strong growth through 2026.BFLY
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - AI-driven ultrasound platform expands with new chips, software, and global partnerships.BFLY
44th Annual J.P. Morgan Healthcare Conference26 Feb 2026 - Record Q4 revenue, positive cash flow, and strong U.S. growth set stage for 2026 expansion.BFLY
Q4 202526 Feb 2026 - Record Q2 revenue, narrowed losses, and improved guidance reflect strong growth and efficiency.BFLY
Q2 20242 Feb 2026 - Revolutionizing ultrasound with digital, AI-enabled devices and strategic licensing for growth.BFLY
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Handheld ultrasound innovation, AI, and global expansion drive strong growth and future disruption.BFLY
2024 CG MedTech, Diagnostics and Digital Health & Services Forum13 Jan 2026 - Advanced handheld ultrasound, AI, and services drive rapid growth and market expansion.BFLY
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - iQ3 launch, global expansion, and AI-driven HomeCare initiatives set the stage for strong growth.BFLY
Oppenheimer 35th Annual Health Care MedTech and Services Conference26 Dec 2025 - Butterfly’s handheld ultrasound aims for mass adoption, leveraging AI and chip licensing for growth.BFLY
Evercore ISI 8th Annual HealthCONx Conference3 Dec 2025